Batten Disease-Neuronal Ceroid Lipofuscinoses (NCL)

Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.

Xiong J1, Kielian T.

Abstract
Juvenile neuronal ceroid lipofuscinosis (JNCL) is a lysosomal storage disease caused by an autosomal recessive mutation in CLN3. Regions of microglial activation precede and predict areas of neuronal loss in JNCL; however, the functional role of activated microglia remains to be defined. The inflammasome is a key molecular pathway for activating pro-IL-1β in microglia, and IL-1β is elevated in the brains of JNCL patients and can induce neuronal cell death. Here, we utilized primary microglia isolated from CLN3(Δex7/8) mutant and wild-type (WT) mice to examine the impact of CLN3 mutation on microglial activation and inflammasome function. Treatment with neuronal lysates and ceramide, a lipid intermediate elevated in the JNCL brain, led to inflammasome activation and IL-1β release in CLN3(Δex7/8) microglia but not WT cells, as well as increased expression of additional pro-inflammatory mediators. Similar effects were observed following either TNF-α or IL-1β treatment, suggesting that CLN3(Δex7/8) microglia exist in primed state and hyper-respond to several inflammatory stimuli compared to WT cells. CLN3(Δex7/8) microglia displayed constitutive caspase-1 activity that when blocked led to increased glutamate release that coincided with hemichannel opening. Conditioned medium from activated CLN3(Δex7/8) or WT microglia induced significant cell death in CLN3(Δex7/8) but not WT neurons, demonstrating that intrinsically diseased CLN3(Δex7/8) neurons are less equipped to withstand cytotoxic insults generated by activated microglia. Collectively, aberrant microglial activation may contribute to the pathological chain of events leading to neurodegeneration during later stages of JNCL.
© 2013 International Society for Neurochemistry.

:: Courtesy NCBI (National Center for Biotechnology Information) Database and The NIH (National Institutes of Health) ::

http://www.ncbi.nlm.nih.gov/pubmed/23919525
http://www.ncbi.nlm.nih.gov/pubmed/22031903


The following product(s) are being used for the research of the above disease, illness or condition
IL 1 beta Human

Interleukin-1 beta Human Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 3500)
Qty
IL 1 beta Human, His

Interleukin-1 beta Human Recombinant, His Tag

5µg - ($ 50)
20µg - ($ 130)
1mg - ($ 2500)
Qty
IL 1 beta Mouse

Interleukin-1 beta Mouse Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 3510)
Qty
IL 1 beta Rat

Interleukin-1 beta Rat Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 4680)
Qty
IL 1 beta Porcine

Interleukin-1 beta Porcine Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 4680)
Qty
IL 1 beta Equine

Interleukin-1 beta Equine Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 4680)
Qty
IL 1 beta Mouse, His

Interleukin-1 beta Mouse Recombinant, His Tag

5µg - ($ 50)
25µg - ($ 130)
1mg - ($ 2700)
Qty
IL 1 Beta Antibody

Interleukin-1b, Mouse Anti-Human

500µg - ($ 155)
1mg - ($ 290)
Qty
IL 1 Beta Antibody, Biotin

Interleukin-1b, Mouse Anti-Human Biotin

500µg - ($ 250)
1mg - ($ 400)
Qty
IL 1 Beta Antibody, FITC

Interleukin-1b, Mouse Anti-Human FITC

500µg - ($ 250)
1mg - ($ 400)
Qty
IL 1 beta Monkey

Interleukin-1 beta Rhesus Macaque Recombinant

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 3500)
Qty
IL 1 beta Human, HEK

Interleukin-1 beta Human Recombinant, HEK

2µg - ($ 50)
10µg - ($ 130)
1mg - ($ 5200)
Qty

Note:

BioInfoMedical is a leading global provider of products and services used in gene, protein and cell research, drug discovery and development, biopharmaceutical manufacturing and transfer of new technologies.

BioInfoMedical specializes in satisfying customers demand for high quality cytokine products including E. coli, insect, and mammalian cell-derived recombinant proteins, monoclonal/polyclonal antibodies, and other cytokine-related reagents.

The specific products and services, offered by BioInfoMedical Biotechnology, range from cytokines and related molecules (such as interleukins, growth factors, chemokines), adhesion molecules, neurotrophic factors, proteases, receptors, developmental proteins, apoptosis and signal transduction-related molecules, and full Technology-License packages with a comprehensive course at ours/customers lab facility. Diagnostic tests are also available in broad spectrum of diseases - Staph, Strep, Malaria, Typhoid, Sexually Transmitted Diseases, Cholera, autoimmune diseases, and diseases like Batten Disease-Neuronal Ceroid Lipofuscinoses (NCL) described on this page..

Please contact us with any questions or inquiries regarding our above stated goals. We will continue to update and improve on this website to meet the needs of You, our customers and to further the larger, global need for disease research and ultimate cures.